Comparison of Peripheral and Cerebral Arterial Flow in Acute Ischemic Stroke: Fimasartan vs. Valsartan vs. Atenolol
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 105 participants.
Also called NCT02403349
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 105 participants
- Registry
-
NCT02403349
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT02403349. Randomized; quadruple masking; primary purpose treatment. Start 2012-05 (registry gives no type); primary completion 2015-05 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of Peripheral and Cerebral Arterial Flow in Acute Ischemic Stroke: Fimasartan vs. Valsartan vs. Atenolol
- Acronym
- FAVOR
- Condition
- Blood Pressure
- Condition
- Ischemic Stroke
- Intervention (Drug)
- Fimasartan
- Intervention (Drug)
- Valsartan
- Intervention (Drug)
- Atenolol
- Lead sponsor
- Ajou University School of Medicine
- Collaborator
- Boryung Pharmaceutical Co., Ltd
Record details
- Record id
cardio:ct-nct02403349- Content hash
61059c18cd14c7774df9ea92677a97c19ecd4ca71198bdb723924308432fb8ab